Why OptimizeRx Corporation’s (OPRX) Stock Is Down 5.18%
As of Monday, November 16, OptimizeRx Corporation’s OPRX share price has dipped by 5.18%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Jenna Brashear
Jenna Brashear
Jenna Brashear
Jenna Brashear
| Share Statistics | OPRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $138.2 | $285.4 | 25% |
|
| Shares Out (Mil) | 18.8 | 55.3 | 29% |
|
| Institutional Ownership | 80.5% | 81.3% | 49% |
|
| Float (Mil) | 14.5 | 45.0 | 24% |
|
| Beta | 1.15 | 1.23 | 68% |
|
| Avg Daily Volume (000s) | 395 | 378 | 53% |
|
| Price Change (52-week) |
(50.6%) | 60.1% | 20% |
|
| Growth | OPRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 20.4% | 13.5% | 82% |
|
| Net Income (5yr) | 34.0% | 5.4% | 88% |
|
| EPS (5yr) | 30.6% | 15.5% | 82 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 24.3% | (15.5%) | 82% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 5 | |
| Current EPS | $0.336 | $0.836 | $1.052 | |
| Month Ago EPS | $0.406 | $0.876 | $1.044 | |
| # Rev Up | 1 | 2 | 3 | |
| # Rev Down | 2 | 0 | 0 | |
| Three Months Ago EPS | $0.413 | $0.890 | $1.058 | |
| Year/Year Chg | (940.0%) | 209.6% | 281.5% | |
| Financials | OPRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $99 | $211 | 26% |
|
| Net Income (TTM) (Mil) | $5 | ($10) | 42% |
|
| EPS (TTM) | $0.246 | ($0.700) | 47% |
|
| Operating Cash Flow (TTM) (Mil) | $18 | $9 | 40% |
|
| Net Cash Flow (TTM) (Mil) | $8 | $3 | 56% |
|
| Long-Term Debt (Q1) (Mil) | $18 | $15 | 32% |
|
| Enterprise Value (Q1) (Mil) | $103 | $190 | 23% |
|
| Valuation | OPRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.05 | 1.14 | 29% |
|
| P/E | 29.7 | 41.2 | 72% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 1.0 | 2.5 | 48% |
|
| Ratios | OPRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 75.3% | 61.3% | 85% |
|
| Net Margin | 5.3% | (21.7%) | 48% |
|
| ROA | 2.8% | (15.6%) | 59% |
|
| ROE | 3.7% | (15.3%) | 40% |
|
| Liabilities to Assets | 20.2% | 32.1% | 13% |
|
| F-Score | 7 | 4 | 82% |
|
OptimizeRx Corporation did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors